Nektar Therapeutics
NKTR
NKTR
166 hedge funds and large institutions have $1.55B invested in Nektar Therapeutics in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 70 increasing their positions, 51 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
166
Holding in Top 10
–
Calls
$3.66M
Puts
$3.54M
Top Buyers
| 1 | +$39.9M | |
| 2 | +$10.8M | |
| 3 | +$8.22M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$7.22M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.47M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$7.55M | |
| 3 | -$6.58M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.77M |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$5.75M |